TrialDiabetes, obesity & metabolism2026

Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1.

Luca Busetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.